{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-247545","form_type":"8-K","ticker":"CNMD","cik":"0000816956","company_name":"CONMED Corp","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.091425+00:00","generated_at":"2026-05-30T08:43:01.434505+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"CONMED Q3 2024: adj. EPS $1.05 beats; revenue guidance trimmed; CEO transition to Beyer Jan 2025","bullets":["Sales $316.7M (+4.0% YoY); GAAP EPS $1.57 (vs $0.50); adjusted EPS $1.05 (+16.7%).","Full-year revenue guidance lowered to $1.300–1.305B from $1.305–1.315B; adj. EPS raised to $4.00–4.05 from $3.95–4.02.","COO Pat Beyer appointed President and CEO effective Jan 1, 2025; Curt Hartman will retire and serve as Special Advisor through March 2027.","Hartman to receive consulting fee of $1.936M plus 2x avg bonus; equity vesting continues through separation date.","Domestic sales +7.4% YoY; international -0.4%; single-use products +6.9%, capital -10.6%."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-247545","json":"https://secwatch.observer/filing/0001193125-24-247545.json","markdown":"https://secwatch.observer/filing/0001193125-24-247545.md","text":"https://secwatch.observer/filing/0001193125-24-247545.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/816956/000119312524247545/0001193125-24-247545-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/816956/000119312524247545/d905685d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:43:01.434505+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2611c64fb6","claim":"Curt R. Hartman changed role as Chair of the Board at CONMED Corp.","evidence_excerpt":"effective as of October 31, 2024, Curt R. Hartman’s service as Chair of the Board will cease","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/816956/000119312524247545/0001193125-24-247545-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"cease"},{"label":"Role","value":"Chair of the Board"}],"fact_type":"executive_change"},{"claim_id":"3e2bb0649c","claim":"Curt R. Hartman was appointed as Special Advisor at CONMED Corp.","evidence_excerpt":"Commencing on March 3, 2025 (the 'Transition Date'), Mr. Hartman will serve as a Special Advisor","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/816956/000119312524247545/0001193125-24-247545-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Special Advisor"}],"fact_type":"executive_change"},{"claim_id":"90a9a6ad3e","claim":"Curt R. Hartman departed as Special Advisor at CONMED Corp.","evidence_excerpt":"As of the Separation Date, Mr. Hartman’s service relationship with the Company will cease.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/816956/000119312524247545/0001193125-24-247545-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will cease"},{"label":"Role","value":"Special Advisor"}],"fact_type":"executive_change"},{"claim_id":"e5217e49f3","claim":"Curt R. Hartman changed role as non-executive officer at CONMED Corp.","evidence_excerpt":"Effective as of January 1, 2025, Mr. Hartman will transition into a non-executive officer role","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/816956/000119312524247545/0001193125-24-247545-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transitioned"},{"label":"Role","value":"non-executive officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}